Overview

Clinical Study of New Intensive Treatment Regimen for Severe Nontuberculous Mycobacterial Pulmonary Disease

Status:
Not yet recruiting

Trial end date:
2025-08-05

Target enrollment:

Participant gender:

Summary

Investigators have selected a number of new drugs, including bedaquiline, to form a regimen to conduct clinical studies for the treatment of severe NTM lung disease.

Phase:

Phase 4

Details

Lead Sponsor:

Shanghai Pulmonary Hospital, Shanghai, China

Collaborators:

Anhui Chest Hospital
Huashan Hospital
No.85 Hospital, Changning, Shanghai, China
Shanghai Public Health Clinical Center
Shanghai Pudong New Area Pulmonary Hospital, China
Zhengzhou Sixth People's Hospital, China